Furthermore, preliminary research has indicated that prompt treatment involving PPARγ agonists or PPARγ activation can significantly enhance neuronal repair and address functional impairments in cases of acute CNS disorders [17, 20–22]. Here, PPARG is linked to central nervous system disorder.